Aripiprazole formulations having increased injection speeds
First Claim
Patent Images
1. A method of treating schizophrenia in a subject in need thereof, comprising intramuscularly administering to said subject a therapeutically effective amount of a pharmaceutical composition at a continuous injection rate of 0.3 mL/s to 1 mL/s, wherein said pharmaceutical composition comprises:
- (a) 24-30 weight percent of a compound of Formula (I);
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to pharmaceutical compositions comprising a compound of Formula (I) that are useful for the intramuscular delivery of antipsychotic drugs using rapid injection rates.
-
Citations
24 Claims
-
1. A method of treating schizophrenia in a subject in need thereof, comprising intramuscularly administering to said subject a therapeutically effective amount of a pharmaceutical composition at a continuous injection rate of 0.3 mL/s to 1 mL/s, wherein said pharmaceutical composition comprises:
(a) 24-30 weight percent of a compound of Formula (I); - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 24)
-
16. A method of treating schizophrenia in a subject in need thereof, comprising intramuscularly injecting into said subject a therapeutically effective amount of a pharmaceutical composition, wherein said pharmaceutical composition comprises:
(a) 24-30 weight percent of a compound of Formula (I); - View Dependent Claims (17)
-
18. A method of treating schizophrenia in a subject in need thereof, comprising intramuscularly injecting into said subject a therapeutically effective amount of a pharmaceutical composition, wherein said pharmaceutical composition comprises:
(a) 24-30 weight percent of a compound of Formula (I); - View Dependent Claims (19)
-
20. A method of treating schizophrenia in a subject in need thereof, comprising intramuscularly injecting into said subject a therapeutically effective amount of a pharmaceutical composition, wherein said pharmaceutical composition comprises:
(a) 24-30 weight percent of a compound of Formula (I); - View Dependent Claims (21)
-
22. A method of treating schizophrenia in a subject in need thereof, comprising intramuscularly injecting into said subject a therapeutically effective amount of a pharmaceutical composition, wherein said pharmaceutical composition comprises:
(a) 24-30 weight percent of a compound of Formula (I); - View Dependent Claims (23)
Specification